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ABSTRACT
Migraine is a common, chronic, incapacitating neurovascular disorder characterized by attacks of severe headache,
autonomic nervous system dysfunction and, in some patients, an aura involving neurological symptoms. Familial hemiplegic
migraine (FHM) is characterized by the presence of hemiparesis and occasionally even severe coma during attacks.
Sporadic hemiplegic migraine has also been described in the literature and has a clinical spectrum similar to FHM.

Migraine affects about 12% of the population in Western
countries.1 Familial hemiplegic migraine (FHM) is the only
variety of m igraine c haracterized b y an a utosomal
dominant pattern of inheritance and transient hemiparesis
followed by migraine headache.2 Some sporadic cases of
hemiplegic migraine with cerebellar signs have also been
r e p o r t e d .3 Sporadic hemiplegic migraine (SHM) has
clinical symptoms identical to FHM and distinct from
migraine with aura.4

multiple analgesics, including intravenous injections for
headache.
On examination at the time of admission, he was opening
eyes on painful stimuli, localizing with the right hand, and
had no verbal response. Power was 0/5 in the left half of
the body with extensor plantar response on the left. He
had a left facial nerve palsy of upper motor neuron type.

CASE REPORT
A 20-year-old right-handed gentleman presented with a 2day history of left-sided weakness (evolving to maximum
deficit over half an hour), followed by severe unilateral
headache, vomiting and altered level of consciousness.
Weakness was preceded by numbness of the left half of
the body, and blurring of vision. There was no history of
fev er, necka che , sp hincte r dys fun ction, ab normal
movement, or head trauma. Over the last 8 years, the
patient had experienced several similar episodes of less
severe intensity, none lastin g more t han 4 hours.
Frequency was variable ranging from 2 per month to once
every 3-4 months. A brain CT scan and cerebrospinal fluid
examination done in 1993 were normal. Subsequent brain
CTs repeated CT at variable intervals were also normal.

Figure 1: Left facial nerve palsy

Pas t med ic al , sur g ica l and fa mil y his to ry wer e
unremarkable. He was unmarried, a non-smoker and did
not consume alcohol. He had quit schooling after the 10th
grade because of his illness. Medication use included
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He was moving the right side spontaneously, and there
were no signs of meningeal irritation. Fundi were normal.
Sensory, cerebellar, and gait examination were deferred.
Routine blood tests including complete blood count, urea,
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Figure 4: EEG showing right hemispheric dysfunction

Figure 2: Left-sided hemiparesis

creatinine, electrolytes, and random sugar were within
normal limits. Anti-epileptic drug levels were in the subtherapeutic range. Magnetic resonance imaging of the
brain (including diffusion-weighted studies) was normal.
EEG showed severe right hemispheric dysfunction. The
patient's family did not consent to CSF analysis. There was
no significant clinical improvement after 3 days of
Figure 5: Repeat EEG showing some improvement

he became fully conscious and oriented, and he was
discharged on above medications. After 3 days, he was
again hospitalized with severe headache, vomiting,
imbalance, and drowsiness. He was given steroids for
status migrainosus and intravenous verapamil (5 mg over
5 minutes), followed by oral verapamil (120 mg twice a
day). Within 48 hours his power returned to normal and
the headache subsided completely. Repeat EEG also
showed improvement. A final diagnosis of SHM was
reached.

Figure 3: T2-weighted MRI of the brain (normal study)

DISCUSSION
hospitalization. An initial diagnosis of epilepsy (made in
the past at another facility) was questioned. On the basis
of a detailed history, exclusion of metabolic abnormalities,
and normal neuroimaging, a diagnosis of sporadic
hemiplegic migraine was tentatively made.
He was started on NSAIDs, flunarizine and valproic acid.
Strength on the affected side gradually improved to 3/5,
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Migraine is characterized by episodes of headache that
are often throbbing, frequently unilateral, and may be
severe. In migraine without aura (previously known as
common migraine), attacks are usually associated with
nausea, vomiting, and sensitivity to light, sound or
movement. A combination of features is required for the
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diagnosis, though not all features are present in every
at tack or every p atient. Any severe and r ecu rrent
headache is most likely to be a form of migraine and to be
responsive to anti-migranous therapy. In 15% of patients,
migraine attacks are usually preceded or accompanied by
transient focal neurological symptoms; such patients have
mig rai ne with a ura (pr evi ou sly kn ow n as cl as sic
migraine).5

metabolic abnormalities associated with focal deficits
(hypercapnia, hypoglycemia, hyponatremia, hypocalcemia,
he pa ti c f ai lur e and re na l f ai lur e ), me ni ngiti s o r
encephalitis, carotid dissection, anti-phospholipid antibody
synd ro me, SLE , and o rni t hine tr ans carb am yla se
deficiency.
Inherited disorders associated with migraine headache
that may include hemiparesis include cerebral autosomal
dominant arteriopathy with subcortical infarcts and
leukoencephalopathy (CADASIL); mitochondrial myopathy,
encephalopathy, lactic acidosis and stroke like episodes
(MELAS); hereditary hemorrhagic telengiectesia (HHT);
hereditary cerebral amyloid angiopathy; familial cerebral
cavernous malformation; and benign familial infantile
convulsions.4

Hemiplegic migraine was initially described in 1910 as a
type of migraine consis ting o f rec urrent headache
ass ocia ted w it h tr an sient he mipa res is . 6 F a m i l i a l
hemiplegic migraine (FHM) is a rare autosomal dominant
form of migraine with aura in which some degree of
hemiparesis is present during attacks. In FHM, the aura
typically lasts longer than in migraine with aura and
usually comprises visual, sensory, aphasic and motor
s y m p t o m s . 7 However, patients with similar clinical
symptoms but without other affected family members
have been reported, and the term sporadic hemiplegic
migraine has been used.8 Based on the literature, two
subforms of FHM families exist - pure FHM in 80% and
F HM f ami lies w ith cere bel lar sym pt om s in 20%. 9
Mutations in the gene CACNA1A, which encodes a
neuronal calcium channel, are present in 50% families
with hemiplegic migraine including those with cerebellar
signs.2 Eight mutations in CACNA1A have been identified
in 18 families affected by hemiplegic migraine and two
patients with SHM.10 Genetic studies have revealed de
novo mutations or incomplete penetrance of CACNA1A in
patients with SHM.2,3 thereby suggesting that SHM may
be part of the spectrum of FHM syndromes.

Current therapeutic recommendations are based on
i sola te d c ase r ep or ts an d i nc l ude pr opra nolo l, 1 1
phenytoin,12 flunarizine,13 and verapamil. 8 Successful
responses of FHM to intravenous verapamil have been
r e p o r t e d .1 4 Verapamil, administered either orally or
intravenously, is also effective for SHM.15 Our patient had
no further episodes after starting oral verapamil 240 mg
daily, and was symptom-free at one-year follow up. SHM
is a relatively rare disorder which should be considered in
pa t ie nt s pr es en ti ng wi th e piso de s of r ev er sibl e
neurological deficits with headaches; a therapeutic trial of
calcium channel blocker (verapamil) may be administered.
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